Back to today’s briefing

Story perspectives

Metformin May Slash Dementia Risk for Obese Patients

8/7/2025

45 11

Summary

Story summary

Taiwanese researchers have uncovered promising news: metformin, a common diabetes medication, may significantly reduce dementia risk in overweight and obese individuals. Analyzing data from 905,000 adults, they found that metformin users enjoyed lower rates of dementia and mortality, hinting at its potential to enhance cognitive health through anti-inflammatory effects.

1 of 1

Story summary

Taiwanese researchers have uncovered promising news: metformin, a common diabetes medication, may significantly reduce dementia risk in overweight and obese individuals. Analyzing data from 905,000 adults, they found that metformin users enjoyed lower rates of dementia and mortality, hinting at its potential to enhance cognitive health through anti-inflammatory effects.